Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

ONCOLOGY

Single-cell RNA sequencing: one step closer to the clinic

Single-cell RNA-sequencing can help in the prediction of drug resistance in patients with multiple myeloma.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. National Cancer Institute Surveillance, Epidemiology, and End Results Program. https://seer.cancer.gov/statfacts/html/mulmy.html (accessed 20 January 2021).

  2. Kumar, S. K. & Rajkumar, S. V. Nat. Rev. Clin. Oncol. 15, 409–421 (2018).

    Article  CAS  Google Scholar 

  3. Nunnelee, J. Z. Q. et al. Blood 134, 4573 (2019).

    Article  Google Scholar 

  4. Thorsteinsdottir, S. et al. Haematologica 103, e412–e415 (2018).

    Article  Google Scholar 

  5. Liu, Y., Tang, C. H., Qiu, H., Siggins, S. & Hou, H. A. Sci. Rep. 11, 1112 (2021).

    Article  CAS  Google Scholar 

  6. Pinto, V. et al. Cancers (Basel) 12, 407 (2020).

    Article  CAS  Google Scholar 

  7. Kumar, S. K. et al. Leukemia 26, 149–157 (2012).

    Article  CAS  Google Scholar 

  8. Cohen, Y.C. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01232-w (2021).

  9. The Multiple Myeloma Research Foundation. https://themmrf.org/finding-a-cure/our-work/the-mmrf-commpass-study/ (2019 accessed 20 January 2021).

  10. Kuiper, R. et al. Blood 126, 1996–2004 (2015).

    Article  CAS  Google Scholar 

  11. Oberle, A. et al. Haematologica 102, 1105–1111 (2017).

    Article  CAS  Google Scholar 

  12. Scheijen, B. et al. Leukemia 33, 2227–2240 (2019).

    Article  Google Scholar 

  13. Gooding, S. et al. Blood 137, 232–237 (2021).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Irene Ghobrial.

Ethics declarations

Competing interests

I.G. has a consulting and advisory role with Celgene, Takeda, Bristol-Myers Squibb, Genentech, Janssen Pharmaceuticals and Amgen, and has received research funding/honoraria from Celgene, Takeda, Bristol-Myers Squibb, Janssen Pharmaceuticals and Amgen. G.G. receives research funds from IBM and Pharmacyclics; is an inventor on patent applications related to MuTect, ABSOLUTE, MutSig, MSMuTect, MSMutSig, MSIdetect, POLYSOLVER and TensorQTL; and is a founder and consultant of and holds privately held equity in Scorpion Therapeutics.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sklavenitis-Pistofidis, R., Getz, G. & Ghobrial, I. Single-cell RNA sequencing: one step closer to the clinic. Nat Med 27, 375–376 (2021). https://doi.org/10.1038/s41591-021-01276-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-021-01276-y

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer